Kamil Ali Jackson
Independent DirectorMs. Kamil Ali-Jackson, Esq., J.D. serves Member of Advisory Board at Syridex Bio. She served as a Partner at Syridex Bio since 2024. She has earlier served as Member of Advisory Board at Syridex Bio. She served as Director at PDS Biotechnology Corporation since February 21, 2020 until October 18, 2026. She co-founded Aclaris Therapeutics, Inc. in July 2012 and served as its Chief Legal Officer since July 2012 until January 2022 and Corporate Secretary since August 2015 until January 2022 also Chief compliance officer since its inception in 2012 until her retirement in January 2022. In addition, since May 2011, in addition, since 2013 She had been a Director of Rigel Pharmaceuticals, Inc. since December 2021 and is its Independent Director. In 2011, Ms. Ali-Jackson also co-founded NeXeption, Inc. Ms. Ali-Jackson has served as the Chief Legal Officer of NeXeption II, LLC, NST, LLC and NST Consulting, LLC. Ms. Ali-Jackson serves as a Partner of NeXeption, LLC. She served as the Chief Legal Officer, Chief Compliance Officer and Secretary of Ceptaris Therapeutics, Inc. (formerly Yaupon Therapeutics, Inc.). She served as Assistant Secretary of Aclaris Therapeutics, Inc. from July 2012 to August 2015. Ms. Ali-Jackson built the legal, compliance and human resources functions at Aclaris. She served as an Interim General Counsel of Iroko Pharmaceuticals, LLC until April 2012. She has legal experience as in-house and external legal counsel in the pharmaceutical, specialty pharmaceutical and biotechnology industries. She has extensive domestic and international legal and business experience in product licensing, commercial transactions, FDA regulatory matters, product liability management and corporate governance matters. From October 2010 to September 2011, she was a consultant to a private specialty pharmaceutical company. Prior to joining Iroko, she served as the General Counsel and Secretary of Ception Therapeutics, Inc. from 2006 to May 2010. Prior to joining Ception Therapeutics, Inc., Ms. Ali-Jackson served as the Associate General Counsel and Vice President of Legal of Dr. Reddy's Laboratories, Inc and its licensing business executive. From January 2014 to December 2015, Ms. Ali-Jackson served part-time as the Chief Legal Officer of Ralexar Therapeutics, Inc. (formerly known as Alexar Therapeutics Inc.). She is member of NST, LLC. Prior to that, Ms. Ali-Jackson served as General Counsel of Caresoft, Inc., a healthcare information and record management company. Before her tenure with Caresoft, she served as the Associate General Counsel and Vice President of Endo Pharmaceuticals, Inc and its licensing business executive. Before joining Endo, she served as Legal Counsel for the vaccine and human health divisions of Merck & Co, Inc. in their human health pharmaceutical and vaccine divisions as well as a Licensing Business Executive. In 2011 and was named a “Woman of Distinction” by the Philadelphia Business Journal. She serves as an independent director of Moda Operandi. She is a member of both the Pennsylvania and New Jersey bars. She has also served on several nonprofit boards and is the Chair of the East Bradford Township Zoning Hearing Board, her local township zoning board. She is on the board of Rosemont College, a private liberal arts college located in Pennsylvania. She was a 2011 Philadelphia Business Journal Woman of Distinction winner and a 2015 Pepper Hamilton, LLP remarkable alumni. Kamil currently serves on the board of directors of two NASDAQ-listed biotechnology companies. Ms. Ali-Jackson obtained her J.D in Law from Harvard Law School in the year 1981 to 1984 and her Bachelor of Arts degree in Politics from Princeton University in the year 1977 to 1981.
Positions
- Company NameRigel Pharmaceuticals, Inc.Stock CodeRIGLPositionIndependent DirectorColleagues
- RRRaul R. RodriguezPresident, CEO & Director
- GAGregory Anthony LapointeIndependent Chairman of the Board
- DLDean L. SchornoExecutive VP & CFO
- RJRaymond J. FureyExecutive VP, Chief Compliance Officer, General Counsel & Corporate Secretary
- DADavid A. SantosExecutive VP & Chief Commercial Officer
- ALAlison L. HannahExecutive VP & Chief Medical Officer
- WHWalter H. MoosIndependent Director
- JWJane WasmanIndependent Director
